Skip to contentW
Whitehawk Therapeutics, Inc.
W
WHWKWhitehawk Therapeutics, Inc. Released Nov 14, 2014, during market hours
10-Q filed Nov 14, 2014, 45 days after period end · 0001213900-14-008152
Q3 2014 · 10-Q
Revenue—
Net Income-$6.43K-$6.43KN/M vs Q3 2013N/M vs Q2 2014 EPS Diluted
No earnings release is on file for this quarter. Its figures came with the 10-Q.
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Whitehawk Therapeutics, Inc. · CIK 1422142 · Engraved from SEC EDGAR
$0.00$0.00— vs Q3 2013no prior Q2 2014 on file Operating Income-$4,765N/M Operating Cash Flowderived-$1,701— Filing lag
ended Sep 30, 2014 · filed Nov 14, 2014 · 45 d after period end